Cost-Effectiveness Analysis of Sunitinib Versus Interferon Alfa for the First-Line Treatment of Advanced And/Or Metastatic Renal Cell Carcinoma in Singapore

Autor:	Fiona Pearce, Kwong Ng, David Bin-Chia Wu, Sil-Ling Pruis, MI Abdul Aziz
Rok vydání:	2018
Předmět:	Oncology medicine.medical_specialty business.industry Sunitinib Health Policy Public Health Environmental and Occupational Health Cost-effectiveness analysis medicine.disease First line treatment Renal cell carcinoma Internal medicine medicine business Interferon alfa medicine.drug
Zdroj:	Value in Health. 21:S15
ISSN:	1098-3015
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::a8790f22d133ac4182b66d1faf2cdb65 https://doi.org/10.1016/j.jval.2018.07.110 Zobrazit plný text záznamu Full Text from ScienceDirect